Eli Lilly
- Collected applications
- 1
- Share of collected applications with IPC
- 0.1%
Coverage is incomplete; counts and shares describe only the collected subset.
View Eli Lilly publications in this fieldCompany patentsCompare
HEAD TO HEAD
Eli LillyNVIDIA
Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.
+ Agricultural Bank of China2025-01 — 2025-12+ Alibaba2025-01 — 2025-12+ Alphabet (Google)2025-01 — 2025-12+ Amazon2025-01 — 2025-12+ Apple2025-01 — 2025-12+ Bank of China2025-01 — 2025-12+ BOE2024-01 — 2024-12+ Broadcom2025-01 — 2025-12+ BYD2024-01 — 2024-12+ CATL2024-01 — 2024-12+ China Construction Bank2025-01 — 2025-12+ China Mobile2025-01 — 2025-12+ CXMT2025-01 — 2025-12✓ Eli Lilly2025-01 — 2025-12+ Huawei2024-01 — 2024-12+ ICBC2025-01 — 2025-12+ Meta2025-01 — 2025-12+ Microsoft2025-01 — 2025-12+ Midea2024-01 — 2024-12+ Kweichow Moutai2025-01 — 2025-12✓ NVIDIA2025-01 — 2025-12+ PetroChina2025-01 — 2025-12+ SpaceX2025-01 — 2025-12+ Tencent2025-01 — 2025-12+ Tesla2025-01 — 2025-12
Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds
This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.
Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.
Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY
NVIDIA: Applicant names included in these statistics — NVIDIA CORPReviewed names not covered — NVIDIA CORP. · NVIDIA CORPORATION
- Publications
- 1,602
- Invention share
- 45%
- Concentration
- 0.73
- Green technology
- —
- Publications
- 2,387
- Invention share
- 81%
- Concentration
- 0.66
- Green technology
- —
0.01Field similarity
01Technology field mirror
The 12 fields with the largest combined share. Share shows structure; count shows scale.
| Eli Lilly | Technology field | NVIDIA |
|---|---|---|
0.6% | Computer technology | 79.3% |
68.5% | Pharmaceuticals | 0% |
39.9% | Biotechnology | 0% |
25.8% | Organic fine chemistry | 0% |
17.6% | Medical technology | 0.5% |
0.1% | Digital communication | 9.1% |
0.1% | Audio-visual technology | 8.8% |
1% | Measurement | 7% |
0% | Transport | 6.9% |
0.6% | Control | 5% |
0.2% | Handling | 2.6% |
0% | Telecommunications | 2.4% |
Inspect one technology field
Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.
NVIDIA
- Collected applications
- 206
- Share of collected applications with IPC
- 8.8%
Coverage is incomplete; counts and shares describe only the collected subset.
View NVIDIA publications in this fieldOne application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.
02Same problem: shared IPC subclasses
The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.
G06FData processing
Eli Lilly2
NVIDIA881
G06TImage processing
Eli Lilly5
NVIDIA719
G06NComputing models, AI
Eli Lilly3
NVIDIA497
G06VImage and video recognition
Eli Lilly2
NVIDIA403
G16H
Eli Lilly36
NVIDIA8
H04WWireless networks
Eli Lilly2
NVIDIA42
A61BMedical diagnosis
Eli Lilly36
NVIDIA5
G01NAnalysing materials
Eli Lilly32
NVIDIA3
G05BControl systems
Eli Lilly4
NVIDIA28
G01RMeasuring electric variables
Eli Lilly3
NVIDIA27
03Where each one leans
Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.
Eli Lilly
- A61K
- Eli Lilly
- 926
- NVIDIA
- —
- A61P
- Eli Lilly
- 766
- NVIDIA
- —
- C07K
- Eli Lilly
- 454
- NVIDIA
- —
- C07DHeterocyclic compounds
- Eli Lilly
- 300
- NVIDIA
- —
- A61M
- Eli Lilly
- 196
- NVIDIA
- —
- C12NMicroorganisms, enzymes
- Eli Lilly
- 153
- NVIDIA
- —
NVIDIA
- G06FData processing
- Eli Lilly
- 2
- NVIDIA
- 881
- G06TImage processing
- Eli Lilly
- 5
- NVIDIA
- 719
- G06NComputing models, AI
- Eli Lilly
- 3
- NVIDIA
- 497
- G06VImage and video recognition
- Eli Lilly
- 2
- NVIDIA
- 403
- H04LDigital transmission
- Eli Lilly
- —
- NVIDIA
- 155
- B60WVehicle sub-unit control
- Eli Lilly
- —
- NVIDIA
- 138
04Publication rhythm
| Period | Eli Lilly | NVIDIA |
|---|---|---|
| 2025-01 | ≥118 (partial coverage) | ≥182 (partial coverage) |
| 2025-02 | ≥121 (partial coverage) | ≥166 (partial coverage) |
| 2025-03 | ≥158 (partial coverage) | ≥170 (partial coverage) |
| 2025-04 | ≥110 (partial coverage) | ≥158 (partial coverage) |
| 2025-05 | ≥134 (partial coverage) | ≥193 (partial coverage) |
| 2025-06 | ≥140 (partial coverage) | ≥183 (partial coverage) |
| 2025-07 | ≥138 (partial coverage) | ≥243 (partial coverage) |
| 2025-08 | ≥134 (partial coverage) | ≥182 (partial coverage) |
| 2025-09 | ≥132 (partial coverage) | ≥265 (partial coverage) |
| 2025-10 | ≥155 (partial coverage) | ≥234 (partial coverage) |
| 2025-11 | ≥140 (partial coverage) | ≥199 (partial coverage) |
| 2025-12 | ≥122 (partial coverage) | ≥212 (partial coverage) |
Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.
Publication timing follows examination and publication cycles, not R&D intensity.
What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.
What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.
Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.